Metoclopramide
| Clinical data | |
|---|---|
| Pronunciation | /ˌmɛtəˈklɒprəmaɪd/ |
| Trade names | Primperan, Maxolon, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a684035 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth, intravenous, intramuscular, nasal spray |
| Drug class | D2 receptor antagonist; 5-HT3 receptor antagonist; 5-HT4 receptor agonist; Prolactin releaser |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 80 ± 15% (by mouth) |
| Metabolism | Liver |
| Elimination half-life | 5–6 hours |
| Excretion | Urine: 70–85% Feces: 2% |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.058 |
| Chemical and physical data | |
| Formula | C14H22ClN3O2 |
| Molar mass | 299.80 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 147.3 °C (297.1 °F) |
| |
| |
| (verify) | |
Metoclopramide is a medication used to treat nausea, vomiting, gastroparesis, and gastroesophageal reflux disease. It is also used to treat migraine headaches.
Common side effects include feeling tired, diarrhea, akathisia, and tardive dyskinesia. More serious side effects include neuroleptic malignant syndrome and depression. It is thus rarely recommended that people take the medication for longer than twelve weeks. No evidence of harm has been found after being taken by many pregnant women. It belongs to the group of medications known as dopamine-receptor antagonists and works as a prokinetic.
In 2012, metoclopramide was one of the top 100 most prescribed medications in the United States. It is available as a generic medication. It is on the World Health Organization's List of Essential Medicines. In 2022, it was the 245th most commonly prescribed medication in the United States, with more than 1 million prescriptions.